West Pharmaceutical Services

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WST and other ETFs, options, and stocks.

About WST

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. 

CEO
Eric Mark Green
CEOEric Mark Green
Employees
10,800
Employees10,800
Headquarters
Exton, Pennsylvania
HeadquartersExton, Pennsylvania
Founded
1923
Founded1923
Employees
10,800
Employees10,800

WST Key Statistics

Market cap
17.31B
Market cap17.31B
Price-Earnings ratio
34.67
Price-Earnings ratio34.67
Dividend yield
0.37%
Dividend yield0.37%
Average volume
900.78K
Average volume900.78K
High today
$242.27
High today$242.27
Low today
$236.20
Low today$236.20
Open price
$237.03
Open price$237.03
Volume
819.80K
Volume819.80K
52 Week high
$322.34
52 Week high$322.34
52 Week low
$187.43
52 Week low$187.43

Stock Snapshot

The current West Pharmaceutical Services(WST) stock price is $240.31, with a market capitalization of 17.31B. The stock trades at a price-to-earnings (P/E) ratio of 34.67 and offers a dividend yield of 36.5%.

During the trading session on 2026-03-17, West Pharmaceutical Services(WST) shares reached a daily high of $242.27 and a low of $236.20. At a current price of $240.31, the stock is +1.7% higher than the low and still -0.8% under the high.

Trading volume for West Pharmaceutical Services(WST) stock has reached 819.8K, versus its average volume of 900.78K.

The stock's 52-week range extends from a low of $187.43 to a high of $322.34.

The stock's 52-week range extends from a low of $187.43 to a high of $322.34.

WST News

Simply Wall St 1d
How Leadership Transition And Governance Debate At West Pharmaceutical Has Changed Its Investment Story

In March 2026, West Pharmaceutical Services reported strong Q4 2025 results and reaffirmed its 2026 guidance, while longtime President, CEO and Board Chair Eric...

How Leadership Transition And Governance Debate At West Pharmaceutical Has Changed Its Investment Story
Simply Wall St 3d
West Pharmaceutical Governance Vote Puts Leadership Structure And Valuation In Focus

A shareholder activist has filed a proposal for West Pharmaceutical Services to permanently separate the CEO and Board Chair roles. The filing coincides with t...

West Pharmaceutical Governance Vote Puts Leadership Structure And Valuation In Focus
Nasdaq 4d
West Pharmaceutical Services Now #396 Largest Company, Surpassing Viatris

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, West Pharmaceutical Services, Inc. (Symbol: WST) has ta...

West Pharmaceutical Services Now #396 Largest Company, Surpassing Viatris

Analyst ratings

79%

of 19 ratings
Buy
78.9%
Hold
21.1%
Sell
0%

More WST News

Simply Wall St 7d
Assessing West Pharmaceutical Services Valuation After Earnings Beat And Upbeat 2026 GLP 1 Guidance

West Pharmaceutical Services (WST) is back in focus after fourth quarter 2025 results beat expectations and management issued upbeat 2026 guidance, highlighting...

Assessing West Pharmaceutical Services Valuation After Earnings Beat And Upbeat 2026 GLP 1 Guidance

People also own

Based on the portfolios of people who own WST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.